ASCOPIAVE S.P.A. financials
ASCOPIAVE S.P.A.
Country: IT Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
815600ABFF26D15A4920 Financial statements
(EUR, as reported — unscaled; 117 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €205.0M | €180.8M |
| Operating expenses | €101.5M | €86.6M |
| Employee benefits expense | €18.2M | €20.9M |
| Raw materials & consumables used | €2.9M | €2.3M |
| Depreciation & amortisation | €51.8M | €48.2M |
| Operating profit (EBIT) | €51.6M | €46.0M |
| Finance costs | €14.9M | €13.9M |
| Profit before tax | €49.3M | €41.6M |
| Income tax expense | €12.8M | €5.0M |
| Profit for the year | €36.5M | €36.7M |
| — attributable to owners | €35.8M | €36.2M |
| — attributable to NCI | €677.0K | €501.0K |
| Total comprehensive income | €34.6M | €19.0M |
| Per share | ||
| Basic EPS | €0.17 | €0.17 |
| Free cash flow / share | €0.39 | €-0.09 |
| Cash flow statement | ||
| Net cash from operating activities | €101.2M | €6.1M |
| Income taxes paid | €6.0M | €1.5M |
| Net cash from investing activities | -€67.6M | €49.1M |
| Purchase of PP&E (capex) | €16.0M | €25.8M |
| Purchase of intangibles | €65.0M | €61.8M |
| Net cash from financing activities | -€51.5M | -€80.0M |
| Dividends paid | €30.3M | €28.5M |
| Proceeds from borrowings | €324.0M | €784.5M |
| Repayments of borrowings | €350.1M | €794.0M |
| Lease liability payments | €1.4M | -€755.0K |
| Balance sheet | ||
| Total assets | €1.45B | €1.46B |
| Non-current assets | €1.10B | €1.28B |
| Property, plant & equipment | €161.9M | €156.5M |
| Intangible assets & goodwill | €61.7M | €61.7M |
| Current assets | €351.1M | €185.5M |
| Inventories | €7.0M | €8.3M |
| Trade & other receivables | €63.1M | €33.4M |
| Cash & equivalents | €34.2M | €52.1M |
| Total equity | €857.8M | €854.3M |
| — attributable to owners | €848.0M | €844.8M |
| Non-controlling interests | €9.8M | €9.5M |
| Non-current liabilities | €379.8M | €361.6M |
| Long-term borrowings | €229.8M | €204.1M |
| Current liabilities | €214.7M | €246.1M |
| Deferred tax liabilities | €17.1M | €17.6M |
| Derived metrics | ||
| Free cash flow | €85.2M | -€19.7M |
| Operating margin | 25.2% | 25.4% |
| Net margin | 17.8% | 20.3% |
| Return on equity | 4.3% | 4.3% |
| Cash conversion ratio | 2.77× | 0.17× |
| Capex coverage | 6.31× | 0.24× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €1.3M | -€940.0K |
| Adjustments For Decrease Increase In Other Assets | €34.9M | -€22.6M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€29.7M | -€13.6M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €51.8M | €48.2M |
| Adjustments For Depreciation Expense | €0 | €3.1M |
| Adjustments For Finance Income Cost | -€14.5M | -€12.2M |
| Adjustments For Income Tax Expense | €12.8M | €5.0M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€311.0K | -€260.0K |
| Adjustments For Increase Decrease In Other Liabilities | -€7.0M | €719.0K |
| Adjustments For Increase Decrease In Trade Account Payable | -€9.9M | -€107.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €3.3M | -€2.1M |
| Adjustments For Sharebased Payments | €81.0K | €0 |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €7.9M | €3.6M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €158.4M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | €7.0M | -€42.8M |
| Comprehensive Income Attributable To Noncontrolling Interests | €441.0K | €515.0K |
| Comprehensive Income Attributable To Owners of Parent | €34.2M | €18.5M |
| Current Bonds Issued and Current Portion of Noncurrent Bonds Issued | €7.6M | €7.7M |
| Current Derivative Financial Assets | €828.0K | €4.8M |
| Current Derivative Financial Liabilities | €832.0K | €0 |
| Current Financial Assets | €816.0K | €1.7M |
| Current Financial Liabilities | €885.0K | €1.6M |
| Current Loans Received and Current Portion of Noncurrent Loans Received | €101.7M | €140.6M |
| Current Tax Assets Current | €491.0K | €4.0M |
| Current Tax Liabilities Current | €4.5M | €795.0K |
| Deferred Tax Assets | €38.5M | €39.3M |
| Dividends Received Classified As Investing Activities | €4.3M | €4.2M |
| Dividends Received From Investments Accounted For Using Equity Method Classified As Investing Activities | €9.2M | €19.0M |
| Dividends Recognised As Distributions To Noncontrolling Interests | — | €331.0K |
| Equity and Liabilities | €1.45B | €1.46B |
| Finance Income | €4.7M | €6.0M |
| Increase Decrease In Cash and Cash Equivalents | -€17.9M | -€24.8M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €0 | -€24.4M |
| Increase Decrease Through Sharebased Payment Transactions | €101.0K | — |
| Increase Decrease Through Transfers and Other Changes Equity | €7.0K | €1.8M |
| Intangible Assets Other Than Goodwill | €725.7M | €704.6M |
| Interest Paid Classified As Operating Activities | €13.3M | €9.0M |
| Investments In Associates Accounted For Using Equity Method | €8.2M | €211.1M |
| Issued Capital | €234.4M | €234.4M |
| Liabilities | €594.5M | €607.7M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €247.0K |
| Miscellaneous Other Operating Expense | €27.7M | €29.9M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €202.4M | €385.0K |
| Noncurrent Financial Assets | €2.2M | €2.5M |
| Noncurrent Financial Liabilities | €6.8M | €7.4M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €97.3M | €97.3M |
| Noncurrent Portion of Noncurrent Bonds Issued | €78.8M | €86.3M |
| Noncurrent Provisions For Employee Benefits | €4.1M | €4.8M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | -€3.2M | -€3.2M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | €0 | -€3.3M |
| Other Comprehensive Income Net of Tax Gains Losses On Hedging Instruments That Hedge Investments In Equity Instruments | €859.0K | -€11.1M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €389.0K | -€75.0K |
| Other Current Assets | €9.6M | €40.9M |
| Other Current Liabilities | €14.1M | €17.2M |
| Other Longterm Provisions | €1.4M | €2.0M |
| Other Noncurrent Assets | €5.7M | €3.5M |
| Other Noncurrent Liabilities | €41.9M | €39.4M |
| Other Reserves | €633.7M | €629.6M |
| Other Revenue | €506.0K | €17.0M |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €0 | €9.4M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €0 | €64.0K |
| Profit Loss From Continuing Operations | €36.5M | €36.6M |
| Profit Loss From Discontinued Operations | €0 | €56.0K |
| Purchase of Interests In Investments Accounted For Using Equity Method | €0 | €54.4M |
| Purchase of Treasury Shares | €854.0K | — |
| Retained Earnings Profit Loss For Reporting Period | €35.8M | €36.2M |
| Services Expense | €53.2M | €50.5M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €7.9M | €3.6M |
| Trade and Other Current Payables To Trade Suppliers | €65.4M | €73.0M |
| Treasury Shares | €56.0M | €55.4M |
Methodology
Every line item above is a fact tagged in ASCOPIAVE S.P.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.